These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28032401)

  • 21. Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts.
    Roland CL; Dineen SP; Lynn KD; Sullivan LA; Dellinger MT; Sadegh L; Sullivan JP; Shames DS; Brekken RA
    Mol Cancer Ther; 2009 Jul; 8(7):1761-71. PubMed ID: 19567820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of vasohibin-1 and -2 predicts poor prognosis among patients with squamous cell carcinoma of the esophagus.
    Ninomiya Y; Ozawa S; Oguma J; Kazuno A; Nitta M; Kajiwara H; Sato Y
    Oncol Lett; 2018 Oct; 16(4):5265-5274. PubMed ID: 30250596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasohibin-1 and -2 in pulmonary lymphangioleiomyomatosis (LAM) cells associated with angiogenic and prognostic factors.
    Inoue C; Miki Y; Saito-Koyama R; Kobayashi K; Seyama K; Okada Y; Sasano H
    Pathol Res Pract; 2022 Feb; 230():153758. PubMed ID: 35026646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preparation of functional antibodies targeting tumor endothelia for the treatment of hepatic carcinoma].
    Hu H; Ran YL; Yu L; Zhou Z; Lou JN; Yang ZH
    Ai Zheng; 2007 May; 26(5):453-7. PubMed ID: 17672931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis.
    Kitahara S; Suzuki Y; Morishima M; Yoshii A; Kikuta S; Shimizu K; Morikawa S; Sato Y; Ezaki T
    Mol Cancer; 2014 May; 13():99. PubMed ID: 24885408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasohibin-2-Targeting Therapies for the Treatment of Pancreatic Ductal Adenocarcinoma.
    Suzuki Y; Sato Y
    Tohoku J Exp Med; 2024 Mar; 262(3):163-171. PubMed ID: 38220168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dll4 Blockade in Stromal Cells Mediates Antitumor Effects in Preclinical Models of Ovarian Cancer.
    Kuhnert F; Chen G; Coetzee S; Thambi N; Hickey C; Shan J; Kovalenko P; Noguera-Troise I; Smith E; Fairhurst J; Andreev J; Kirshner JR; Papadopoulos N; Thurston G
    Cancer Res; 2015 Oct; 75(19):4086-96. PubMed ID: 26377940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wide spectrum of antitumor activity of a neutralizing monoclonal antibody to human vascular endothelial growth factor.
    Asano M; Yukita A; Suzuki H
    Jpn J Cancer Res; 1999 Jan; 90(1):93-100. PubMed ID: 10076571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteolytic inactivation of anti-angiogenic vasohibin-1 by cancer cells.
    Saito M; Suzuki Y; Yano S; Miyazaki T; Sato Y
    J Biochem; 2016 Oct; 160(4):227-232. PubMed ID: 27169581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticancer activity of TTAC-0001, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR-2/KDR) monoclonal antibody, is associated with inhibition of tumor angiogenesis.
    Kim DG; Jin Y; Jin J; Yang H; Joo KM; Lee WS; Shim SR; Kim SW; Yoo J; Lee SH; Yoo JS; Nam DH
    MAbs; 2015; 7(6):1195-204. PubMed ID: 26325365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor effect of isoquercetin on tissue vasohibin expression and colon cancer vasculature.
    da Silva DC; Orfali GDC; Santana MG; Palma JKY; Assunção IRO; Marchesi IM; Grizotto AYK; Martinez NP; Felliti S; Pereira JA; Priolli DG
    Oncotarget; 2022; 13():307-318. PubMed ID: 35145607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plumbagin restrains hepatocellular carcinoma angiogenesis by suppressing the migration and invasion of tumor-derived vascular endothelial cells.
    Wei Y; Yang Q; Zhang Y; Zhao T; Liu X; Zhong J; Ma J; Chen Y; Zhao C; Li J
    Oncotarget; 2017 Feb; 8(9):15230-15241. PubMed ID: 28122355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer immunotherapy of targeting angiogenesis.
    Hou J; Tian L; Wei Y
    Cell Mol Immunol; 2004 Jun; 1(3):161-6. PubMed ID: 16219162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.
    Prewett M; Huber J; Li Y; Santiago A; O'Connor W; King K; Overholser J; Hooper A; Pytowski B; Witte L; Bohlen P; Hicklin DJ
    Cancer Res; 1999 Oct; 59(20):5209-18. PubMed ID: 10537299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Endothelial SCUBE2 (Signal Peptide-CUB-EGF Domain-Containing Protein 2), a Novel VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) Coreceptor, Suppresses Tumor Angiogenesis.
    Lin YC; Liu CY; Kannagi R; Yang RB
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1202-1215. PubMed ID: 29545238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maintenance treatment with bevacizumab prolongs survival in an in vivo ovarian cancer model.
    Mabuchi S; Terai Y; Morishige K; Tanabe-Kimura A; Sasaki H; Kanemura M; Tsunetoh S; Tanaka Y; Sakata M; Burger RA; Kimura T; Ohmichi M
    Clin Cancer Res; 2008 Dec; 14(23):7781-9. PubMed ID: 19047105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual-function synthetic peptide derived from BMP4 for highly efficient tumor targeting and antiangiogenesis.
    Choi SH; Lee JY; Suh JS; Park YS; Chung CP; Park YJ
    Int J Nanomedicine; 2016; 11():4643-4656. PubMed ID: 27695323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MEDI3617, a human anti-angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models.
    Leow CC; Coffman K; Inigo I; Breen S; Czapiga M; Soukharev S; Gingles N; Peterson N; Fazenbaker C; Woods R; Jallal B; Ricketts SA; Lavallee T; Coats S; Chang Y
    Int J Oncol; 2012 May; 40(5):1321-30. PubMed ID: 22327175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel.
    Inoue K; Slaton JW; Davis DW; Hicklin DJ; McConkey DJ; Karashima T; Radinsky R; Dinney CP
    Clin Cancer Res; 2000 Jul; 6(7):2635-43. PubMed ID: 10914704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The vasohibin family: a novel family for angiogenesis regulation.
    Sato Y
    J Biochem; 2013 Jan; 153(1):5-11. PubMed ID: 23100270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.